Learn the basics

What is GLP-1? Understanding the hormone and the medicines

A beginner’s guide to GLP-1, receptor agonists, semaglutide and tirzepatide, with a practical way to identify what an online treatment service offers.

By CoreAge Rx · Published · Updated · 4 min read

Published by CoreAge Rx. This is company-published educational and promotional content, not an independent review or third-party endorsement.

General education; individual care decisions require a licensed clinician. This article does not report a clinical review or study of CoreAge Rx patients.

The quick answer

GLP-1 stands for glucagon-like peptide-1, a hormone involved in the body’s response to food. In conversations about treatment, “a GLP-1” usually means a prescription medicine that activates this hormone’s receptor. The hormone, an active drug ingredient, a finished medication and the service supplying care are different things.

The hormone starts with a signal from the gut

After food arrives in the digestive system, intestinal cells release GLP-1. Among its effects, it helps the pancreas respond to rising glucose with insulin and briefly slows stomach emptying. NIDDK’s history of GLP-1 research explains how scientists connected this meal-related signal with blood sugar regulation.

The body breaks down its natural GLP-1 quickly. Researchers therefore needed longer-lasting molecules to make practical medicines. Having a normal gut hormone and taking a medication that acts on its receptor are different biological situations; the word “natural” does not explain a prescription’s benefits or risks.

“Receptor agonist” means it activates a receiving point

A receptor is a protein through which a cell can receive a signal. An agonist activates that receptor. The term describes a medicine’s action, rather than a brand, an injection device or an online membership.

Semaglutide is one example. The Wegovy prescribing information describes it as binding to and activating the GLP-1 receptor. That label also describes appetite-related effects, reduced calorie intake and glucose-dependent effects on insulin and glucagon. This is more specific than saying that the medication simply “burns fat.”

Semaglutide and tirzepatide are not two names for one drug

Tirzepatide activates both GLP-1 and GIP receptors, as the Zepbound prescribing information explains. GIP is another hormone signal involved in this area of treatment. This is why tirzepatide is described as a dual receptor agonist even when a headline places it under the broad GLP-1 label.

The distinction identifies how the medicines act; it does not decide which treatment is best for a particular person. Nor does a shared receptor target make two products’ instructions interchangeable. Start by identifying the actual ingredient and product, then discuss the relevant evidence and instructions with the prescriber.

How the science becomes an individual care plan

A mechanism explains part of what a drug does. Choosing treatment requires a separate assessment of the person receiving it. NIDDK’s weight-management medication guide describes factors including health conditions, other medicines, possible side effects, expected benefits and cost. Medication is considered alongside nutrition, physical activity and other appropriate support.

For example, two people may both ask about “a GLP-1” while seeking care for different health concerns and taking different medicines already. Their conversations need to cover those details. An online price or a friend’s experience cannot answer the clinical questions on their behalf.

Where CoreAge Rx fits in this vocabulary

CoreAge Rx is a telehealth service, not the name of a drug ingredient. Its product overview lists compounded semaglutide and tirzepatide among its prescription offerings. The same page separately lists a non-prescription supplement called GLP-1 Support. A supplement name containing “GLP-1” does not make it semaglutide, tirzepatide or a prescription receptor agonist.

Compounded medicines are not FDA-approved. FDA’s guidance says they should be used only when an approved drug cannot meet the patient’s medical needs. The mechanisms and trial findings of approved products do not establish the quality, suitability or results of a particular compounded preparation.

When exploring the CoreAge Rx service overview, keep the product question separate from the service question. Ask what is being prescribed, why it is being considered for you, which pharmacy would dispense it and how you would receive instructions. Our offer documentation guide helps you keep those answers together.

Keep the exact product in view after enrollment

The broad GLP-1 category remains useful for learning, but the actual prescription controls the practical details. Read the label and supplied instructions with the pharmacy, including storage and how to ask about anything unclear. The program name alone does not tell you whether a shipment has been handled correctly.

If an injectable delivery arrives warm or damaged, use the delivery concern guide for the relevant FDA advice and contacts. Understanding what the treatment is makes it easier to recognize which questions belong with the clinician, pharmacy or ordering service.

Common questions

Is GLP-1 a brand name?

No. It is the shortened name of a hormone. “GLP-1 medicines” refers to treatments acting on its receptor; specific medicines have ingredient and product names.

Does my body already make GLP-1?

Yes. The gut releases the hormone as part of its response to food. A prescription that activates the GLP-1 receptor is not the same as that short-lived natural signal.

Is every product with GLP-1 in its name a prescription medicine?

No. Read the ingredient list and product category. A supplement marketed with GLP-1 wording is not automatically a GLP-1 receptor agonist.

Sources and fact-checking

Sources checked 2026-09-09. CoreAge Rx pages support descriptions of its service; medical and regulatory sources support the educational context. Offers and availability can change.

  1. NIDDK: research behind GLP-1 medicines
  2. DailyMed: Wegovy mechanism and prescribing information
  3. DailyMed: Zepbound mechanism and prescribing information
  4. NIDDK: prescription medication decisions for weight management
  5. CoreAge Rx: product categories and prescription offerings
  6. FDA: unapproved GLP-1 products and compounding